0.64
-4.51%
Close of 9 Nov 2026, in HKD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Zhongzhi Pharmaceutical Holdings
Its shares trade on HKEX under the ticker 3737.HK. It has been listed since 13 July 2015. In the fiscal year to 31 December 2025, it reported revenue of CN¥1.74bn and net income of CN¥17.3m. At that date it held total assets of CN¥1.83bn and shareholders' equity of CN¥1.10bn.
Zhongzhi Pharmaceutical Holdings Ltd. engages in the manufacture and sale of pharmaceutical products. The company is headquartered in Zhongshan, Guangdong. The company went IPO on 2015-07-13. The firm is principally engaged in the research and development, manufacturing and sales of Chinese patent medicines and decoction pieces (consisting of traditional decoction pieces and modern decoction pieces). The firm operates through three segments: pharmaceutical manufacturing segment, operation of chain pharmacies in Zhongshan, Guangdong Province and operation of on-line pharmacies. The Company’s brands include Zeus, Liumian and Caojinghua. The firm mainly conducts its businesses in the domestic market.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Pharmaceuticals
- Listed since
- 13 Jul 2015
- Employees
- 2,834
- Website
- zeus.cn ↗
Leadership
Pay as last reported
- Mr. Zhi Tian LaiExecutive Chairman of the Board, since 2021CN¥1.4m
- Mr. Ying Feng LaiChief Executive Officer, Executive Director, since 2018CN¥1.1m
- Mr. Ying Sheng LaiChief Financial Officer, Executive Director, since 2021
- Mr. Xiao Jun CaoVice President, Executive Director, since 2021CN¥1.1m
- Mr. Gui Quan HeVice President - Responsible for the Management of Production Segments
- Mr. Wei Lin QiaoVice President - Technical Research and Development, Quality Control, Chinese Medicine Resources Management and Administration
- Mr. Qiang RanVice President
- Mr. Jiong ChenGeneral Manager - Guangdong Caojinghua Cell-broken Herb Company Limited, since 2015
- Ms. Man Na ShenGeneral Manager - Zhongzhi Chain Pharmacies
- Mr. Lin TangHead of the Technical Development Department of Honeson Pharmaceutical
- Ms. Wing Yan HoCompany Secretary
- Mrs. Li Xia JiangNon-Executive Director, since 2014CN¥261,000
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Zhongzhi Pharmaceutical Holdings Ltd employs 2,834 full-time employees in Zhongshan, Guangdong.
- The company operates three business segments including pharmaceutical manufacturing and chain pharmacies.
- Zhongzhi's brands Zeus, Liumian, and Caojinghua are key to its domestic market presence.
Weaknesses
- The company's business is primarily limited to the domestic market in China.
- Zhongzhi's operations are concentrated in Zhongshan, Guangdong Province, limiting regional expansion.
- The firm's IPO on 13 July 2015 may indicate limited international exposure.
Opportunities
- Expanding the operation of on-line pharmacies could reach broader domestic consumers.
- Growth in the Chinese patent medicine segment offers potential market expansion.
- Increasing the operation of chain pharmacies in Zhongshan could enhance market share.
Threats
- Dependence on the domestic market exposes Zhongzhi to local economic fluctuations.
- Competition from other pharmaceutical firms in Guangdong Province may increase.
- Regulatory changes in China's pharmaceutical industry could impact operations.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.